94295 ⎘
Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines with a hetero atom directly attached to the ring nitrogen atom
COMPOUNDS AND METHODS FOR YAP/TEAD MODULATION AND INDICATIONS THEREFOR
#2COMPOUNDS AND METHODS FOR YAP/TEAD MODULATION AND INDICATIONS THEREFOR
#3COMPOUNDS AND METHODS FOR YAP/TEAD MODULATION AND INDICATIONS THEREFOR
#4AMINOTETRALINE ACTIVATORS OF SEROTONIN RECEPTORS
#5COMPOUNDS AND METHODS FOR YAP/TEAD MODULATION AND INDICATIONS THEREFOR
#6RXFP1 AGONISTS
#7SIGMA LIGAND COMPOUNDS AND USES THEREOF
#8AMINOTETRALINE ACTIVATORS OF SEROTONIN RECEPTORS
#9COMPOUNDS AND METHODS FOR YAP/TEAD MODULATION AND INDICATIONS THEREFOR
#10Chilled Compressed Air Electric Vehicle (EV) Fast-Charge System and Method
#11Aminotetraline activators of serotonin receptors
#12PROTEIN-PROTEIN INTERACTION STABILIZERS
#13Sigma ligand compounds and uses thereof
#14Diversity-oriented synthesis of N,N,O-trisubstituted hydroxylamines from alcohols and amines by N—O bond formation
#15NRF2 ACTIVATOR
#16Tetrahydroisoquinoline compound, preparation method therefor, pharmaceutical composition containing same, and use thereof
#17ACLY inhibitors and uses thereof
#18NRF2 activator
#19IRE-1α inhibitors
#20Antagonists of the kappa opioid receptor
#21Substituted tetrahydroisoquinoline ethylbenzamide anti-cancer agents
#22Actinic ray-sensitive or radiation-sensitive resin composition, resist film, pattern forming method, and method for manufacturing electronic device
#23TETRAHYDROISOQUINOLINE DERIVATIVES
#24IRE-1α inhibitors
#25PRMT5 INHIBITORS CONTAINING A DIHYDRO- OR TETRAHYDROISOQUINOLINE AND USES THEREOF
#26Inhibitors of human immunodeficiency virus replication
#27Tetracyclic pyridone compounds as antivirals
#28IRE-1α inhibitors
#29Antagonists of the kappa opioid receptor
#30PRMT5 inhibitors and uses thereof
#31Piperazine derivatives as FASN inhibitors
#32Substituted 1,2,3,4-tetrahydroisoquinoline derivatives for the treatment of hormone-dependent diseases
#33Substituted hydroxamic acids and uses thereof
#34PRMT5 inhibitors containing a dihydro- or tetrahydroisoquinoline and uses thereof
#35Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin
#36ACTINIC RAY-SENSITIVE OR RADIATION-SENSITIVE RESIN COMPOSITION, RESIST FILM USING THE SAME, PATTERN FORMING METHOD, AND METHOD FOR MANUFACTURING ELECTRONIC DEVICE AND ELECTRONIC DEVICE, AND COMPOUND
#37IRE-1α inhibitors
#38Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin
#39Hedgehog pathway modulators
#40COMPOUNDS THAT INHIBIT (BLOCK) BITTER TASTE IN COMPOSITION AND METHODS OF MAKING SAME
#41N-aminotetrahydroisoquinolines as anti-cancer agents
#42Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin
#43Actinic-ray- or radiation-sensitive resin composition, compound and method of forming pattern using the composition
#44Phenalkylamine derivatives, pharmaceutical compositions containing them, and their use in therapy
#45Inhibitor compounds of 11-beta-hydroxysteroid dehydrogenase type 1
#46Phenylalanine derivatives and their use as non-peptide GLP-1 receptor modulators
#47Compounds that inhibit (block) bitter taste in composition and methods of making same
#48Compounds and compositions as hedgehog pathway inhibitors
#49Fused polycyclic aromatic compound and organic light emitting device using the compound
#50Substituted hydroxamic acids and uses thereof
#51ACTINIC-RAY- OR RADIATION-SENSITIVE RESIN COMPOSITION, COMPOUND AND METHOD OF FORMING PATTERN USING THE COMPOSITION
#52Biclycloheteroaryl Compounds as P2x7 Modulators and Uses Thereof
#53Systems and methods for processing access control lists (ACLS) in network switches using regular expression matching logic
#54Pyridine, quinoline, and isoquinoline N-oxides as kinase inhibitors
#55Aminotetralin-derived urea modulators of vanilloid VR1 receptor
#56Azadecalin glucocorticoid receptor modulators
#57Cyclopropane compounds and pharmaceutical use thereof
#58COMPOUNDS AND COMPOSITIONS AS MODULATORS OF GPR119 ACTIVITY
#59Compounds that inhibit (block) bitter taste in composition and use thereof
#60Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin
#61Sulfonamide compounds as cysteine protease inhibitors
#62Sulfonamide derivatives and use thereof for the modulation of metalloproteinases
#63Novel 8-Sulfonyl-3 Aminosubstituted Chroman or Tetrahydronaphtalene Derivatives Modulating the 5HT6 Receptor
#64Arylsulfonamides and uses related thereto
#65Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin
#66Cyclopropane compounds and pharmaceutical use thereof
#67CYCLOPROPANE COMPOUNDS AND PHARMACEUTICAL USE THEREOF
#68MODULATORS OF ACETYL-COENZYME A CARBOXYLASE AND METHODS OF USE THEREOF
#69SYSTEMS AND METHODS FOR PROCESSING ACCESS CONTROL LISTS (ACLS) IN NETWORK SWITCHES USING REGULAR EXPRESSION MATCHING LOGIC
#70Aminotetralin-derived urea modulators of vanilloid VR1 receptor
#71Pyridine, quinoline, and isoquinoline N-oxides as kinase inhibitors
#72Azadecalin Glucocorticoid receptor modulators
#73Hydroxysteroid dehydrogenase inhibitors
#74Preventives/remedies for urinary disturbance
#75Cyclopropane compounds and pharmaceutical use thereof
#76Preventives/remedies for urinary disturbance
#77Use of aryl- and heteroaryl-substituted tetrahydroisoquinolines to block reuptake of norepinephrine, dopamine, and serotonin
#78Novel nitrosation polymer in organic synthesis
#79Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin
#80Compounds for treatment of neurodegenerative diseases
#81Arylsulfonamides and uses related thereto
#82Tetrahydroisoquinoline derivatives
#83Preventives/remedies for urinary disturbance
#84Aminotetralin-derived urea modulators of vanilloid VR1 receptor
#85Antibacterial agents
#86Heteroaromatic urea derivatives as VR-1 receptor modulators for treating pain
#87Novel potassium channels modulators
#88N-substituted tetrahydroisoquinoline benzamides/benzene sulfonamides as anti-cancer agents